User profiles for "author:Katja Steiger"
Katja SteigerInstitute of Pathology Verified email at tum.de Cited by 5473 |
[HTML][HTML] Exploring the role of RGD-recognizing integrins in cancer
M Nieberler, U Reuning, F Reichart, J Notni, HJ Wester… - Cancers, 2017 - mdpi.com
Integrins are key regulators of communication between cells and with their
microenvironment. Eight members of the integrin superfamily recognize the tripeptide motif …
microenvironment. Eight members of the integrin superfamily recognize the tripeptide motif …
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
F Alfei, K Kanev, M Hofmann, M Wu, HE Ghoneim… - Nature, 2019 - nature.com
Cytotoxic T cells are essential mediators of protective immunity to viral infection and
malignant tumours and are a key target of immunotherapy approaches. However, prolonged …
malignant tumours and are a key target of immunotherapy approaches. However, prolonged …
Structure-preserving color normalization and sparse stain separation for histological images
Staining and scanning of tissue samples for microscopic examination is fraught with
undesirable color variations arising from differences in raw materials and manufacturing …
undesirable color variations arising from differences in raw materials and manufacturing …
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
S Mueller, T Engleitner, R Maresch, M Zukowska… - Nature, 2018 - nature.com
The poor correlation of mutational landscapes with phenotypes limits our understanding of
the pathogenesis and metastasis of pancreatic ductal adenocarcinoma (PDAC). Here we …
the pathogenesis and metastasis of pancreatic ductal adenocarcinoma (PDAC). Here we …
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
T Wartewig, Z Kurgyis, S Keppler, K Pechloff… - Nature, 2017 - nature.com
T cell non-Hodgkin lymphomas are a heterogeneous group of highly aggressive
malignancies with poor clinical outcomes. T cell lymphomas originate from peripheral T cells …
malignancies with poor clinical outcomes. T cell lymphomas originate from peripheral T cells …
NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
C Heining, P Horak, S Uhrig, PL Codo, B Klink, B Hutter… - Cancer discovery, 2018 - AACR
We used whole-genome and transcriptome sequencing to identify clinically actionable
genomic alterations in young adults with pancreatic ductal adenocarcinoma (PDAC) …
genomic alterations in young adults with pancreatic ductal adenocarcinoma (PDAC) …
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
J Weber, R Öllinger, M Friedrich… - Proceedings of the …, 2015 - National Acad Sciences
Here, we show CRISPR/Cas9-based targeted somatic multiplex-mutagenesis and its
application for high-throughput analysis of gene function in mice. Using hepatic single guide …
application for high-throughput analysis of gene function in mice. Using hepatic single guide …
[HTML][HTML] Non-canonical functions of SNAIL drive context-specific cancer progression
MC Paul, C Schneeweis, C Falcomatà, C Shan… - Nature …, 2023 - nature.com
SNAIL is a key transcriptional regulator in embryonic development and cancer. Its effects in
physiology and disease are believed to be linked to its role as a master regulator of …
physiology and disease are believed to be linked to its role as a master regulator of …
[HTML][HTML] Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
R Maresch, S Mueller, C Veltkamp, R Öllinger… - Nature …, 2016 - nature.com
Mouse transgenesis has provided fundamental insights into pancreatic cancer, but is limited
by the long duration of allele/model generation. Here we show transfection-based …
by the long duration of allele/model generation. Here we show transfection-based …
[PDF][PDF] A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity
P Meiser, MA Knolle, A Hirschberger, GP de Almeida… - Cancer Cell, 2023 - cell.com
Type 1 conventional dendritic cells (cDC1) can support T cell responses within tumors but
whether this determines protective versus ineffective anti-cancer immunity is poorly …
whether this determines protective versus ineffective anti-cancer immunity is poorly …